Most people with high cholesterol have no idea they have it, because the condition almost never causes symptoms you can feel. There is no headache, no fatigue, no telltale sign that tips you off. The only reliable way to find out is a blood test called a lipid panel. That simplicity is both reassuring and easy to put off, which is why understanding what the test measures, when to get one, and what can make the results misleading matters more than most people realize.
Why You Cannot Feel High Cholesterol
Cholesterol circulates in your blood attached to protein particles. Even when levels are dangerously high, these particles do not trigger pain receptors, cause inflammation you can perceive, or produce any sensation at all. The damage happens slowly and internally: excess cholesterol deposits in artery walls over years and decades, gradually narrowing blood vessels. By the time that process causes something you notice, such as chest pain during exertion or a heart attack, the disease has been building for a long time. A review of the evidence on screening asymptomatic adults confirmed that elevated total cholesterol and LDL cholesterol are risk factors for coronary disease and early mortality in middle-aged adults, and that lowering cholesterol reduces the incidence of coronary events, but the key word is “asymptomatic.” The condition is clinically silent until it is not.1Annals of Internal Medicine. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level
Rare Physical Signs Worth Knowing About
There is one exception to the “no symptoms” rule, and it applies mostly to people with a genetic condition called familial hypercholesterolemia (FH). In these individuals, LDL cholesterol can be so high from birth that cholesterol deposits show up in visible places on the body. Three physical signs have been linked to FH: tendon xanthomas (firm, yellowish lumps on tendons, especially the Achilles tendon and knuckles), xanthelasma (flat yellowish patches on or around the eyelids), and corneal arcus (a whitish or grayish ring around the iris of the eye).2Journal of Cardiovascular Medicine. Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry A case report described a 23-year-old woman with the severe, homozygous form of FH who presented with all of these signs plus hand deformities, with an LDL cholesterol of 509 mg/dL.3PubMed Central. Corneal Arcus, Xanthomas, and Finger Deformities in a Young Woman With Homozygous Familial Hypercholesterolemia
These signs can raise suspicion of FH in people who appear otherwise healthy, particularly when corneal arcus appears in someone under 45.4PubMed. The value of physical signs in identifying patients with familial hypercholesterolemia in the era of genetic testing But the vast majority of people with high cholesterol, even moderately high cholesterol that needs treatment, will never develop any of these physical signs. Waiting until you can see something is not a strategy.
What a Lipid Panel Actually Measures
The standard blood test for cholesterol is called a lipid panel or lipid profile. It typically reports four numbers: total cholesterol, LDL cholesterol (the type most closely linked to artery plaque), HDL cholesterol (the type associated with clearing cholesterol from arteries), and triglycerides (a type of fat in your blood that contributes to cardiovascular risk through different mechanisms). Some labs also calculate non-HDL cholesterol, which is simply your total cholesterol minus your HDL. This number captures all the potentially harmful cholesterol-carrying particles at once, which is useful when triglycerides are elevated.
LDL cholesterol is the number most treatment decisions revolve around. In most labs, your LDL is not measured directly but calculated from the other values using a formula. This calculation works well for most people but becomes unreliable when triglycerides are very high. When that happens, labs can switch to direct measurement methods (called homogeneous assays), which have been shown to meet precision and accuracy requirements and to classify people into risk categories better than the traditional calculation, particularly in samples with unusual lipoprotein patterns.5Clinical Chemistry. Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation Newer estimation methods have also improved accuracy across the board, especially at low LDL levels and in non-fasting samples.6PubMed. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy
Do You Need to Fast Before the Test?
For decades, doctors told patients to fast for 9 to 12 hours before a cholesterol test. The rationale was that eating raises triglycerides temporarily, which would throw off the LDL calculation. This advice is slowly changing. A large meta-analysis of over 244,000 participants found that while there are statistically measurable differences between fasting and non-fasting values for all lipid components, the clinical impact for most people is small.7PubMed Central. Unraveling the controversy between fasting and nonfasting lipid testing in a normal population: a systematic review and meta-analysis of 244,665 participants Research has also shown that fasting and non-fasting lipid panels are similar regardless of whether someone takes a statin, which means you likely do not need to fast even if you are on cholesterol-lowering medication.8PubMed Central. The difference between fasting and non-fasting lipid measurements is not related to statin treatment
Many guidelines in Europe and elsewhere now accept non-fasting samples as the default. In the United States, practice is more mixed, with some doctors still requesting fasting and others not. If your triglycerides come back very high on a non-fasting test, your doctor may ask you to repeat the test after fasting to get a more precise LDL estimate. For routine screening, though, the convenience of skipping the fast generally outweighs the small accuracy trade-off.
When and How Often to Get Tested
For most adults, U.S. guidelines suggest starting cholesterol screening at age 20 and repeating it roughly every five years if your numbers look normal. The optimal interval is not set in stone. The U.S. Preventive Services Task Force has noted that shorter intervals make sense for people whose levels are close to treatment thresholds, while longer intervals are reasonable for people at low risk with consistently normal results.9U.S. Preventive Services Task Force. Lipid Disorders in Adults: Screening
Children are a separate story. The National Heart, Lung, and Blood Institute and the American Academy of Pediatrics recommend universal screening once between ages 9 and 11, and again between ages 17 and 21. Children with a family history of early heart disease or very high cholesterol can be screened as early as age 2.10JAMA. Screening for Lipid Disorders in Children and Adolescents The rationale is to catch familial hypercholesterolemia early, since it affects roughly 1 in 250 people and treatment in childhood can prevent decades of artery damage.11PubMed Central. Screening and Management of Dyslipidemia in Children and Adolescents Not every country agrees with universal pediatric screening. A systematic review of international guidelines found recommendations ranging from strong support to outright negative statements, reflecting genuine uncertainty about the balance of benefit versus unnecessary worry in children.12Pediatric Research. Current guidelines on screening, diagnosis and management of dyslipidaemia in childhood: a systematic review
Why a Single Test Can Be Misleading
Your cholesterol level on any given day is not a fixed number. A study measuring lipids on three separate occasions in the same people found day-to-day variability of about 5% for total cholesterol, 20% for triglycerides, 10% for HDL, and 8% for LDL.13PubMed. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels That might sound small, but it means a total cholesterol of 200 on Monday could genuinely read 190 or 210 on Thursday without anything having changed in your diet or health. Longer-term data shows even more variation: within a single year, an individual’s cholesterol can swing by up to about 11%, and triglycerides by as much as 41%.14Atherosclerosis. Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans More than 60% of this variation is biological, meaning it is not caused by lab error but by normal fluctuations in your metabolism.
The practical takeaway is that if your numbers land near a treatment threshold, one test is not enough to make a decision. Most guidelines and experienced clinicians will recheck before starting medication, and some will average two or three readings taken weeks apart. If your numbers are dramatically high or dramatically normal, a single test is more trustworthy; it is the borderline cases where repeating matters most.
At-Home Cholesterol Tests
You can buy cholesterol self-testing kits at pharmacies or online. These use a finger-prick blood sample and give you a result in minutes. The question is whether you can trust that result. A study evaluating five commercially available cholesterol self-tests found enormous variation in accuracy. The best-performing device had an average error of about 6% compared to lab testing, with 92% sensitivity and 89% specificity. The worst-performing device had an average error of about 20%.15PubMed. Performance of commercially-available cholesterol self-tests Most of these devices only measure total cholesterol. The ones that also report HDL showed poor performance for the cholesterol-to-HDL ratio, which limits their usefulness for actual risk assessment. A home test might be useful as a rough gauge between doctor visits, but it should not replace a proper lab lipid panel for clinical decision-making.
Tests Beyond the Standard Panel
A standard lipid panel is the starting point, but it does not capture everything about your cholesterol-related risk. Several additional tests can fill in the gaps, and knowing they exist is useful if you’re in a gray zone where the standard numbers do not clearly tell you or your doctor what to do.
Apolipoprotein B, often abbreviated apoB, is a protein found on every LDL particle (and every other artery-clogging lipoprotein particle). Measuring apoB gives you a direct count of how many of these harmful particles are circulating, which can be more informative than just knowing the total amount of cholesterol they carry. Two people can have the same LDL cholesterol number but very different numbers of LDL particles, and the person with more particles generally has higher risk. Expert panels have determined that apoB can be measured cheaply, accurately, and more precisely than LDL cholesterol itself.16PubMed Central. Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol Each atherogenic lipoprotein particle contains one molecule of apoB, making it a straightforward surrogate for particle number.17PubMed. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
Lipoprotein(a), written as Lp(a), is a genetically determined variant of LDL that carries extra risk for heart disease and is not reflected in your standard LDL number. Because Lp(a) is almost entirely controlled by genetics and does not change much with diet or exercise, experts recommend measuring it at least once in every person’s lifetime. Knowing your level can tip the scales in borderline treatment decisions; for instance, an elevated Lp(a) may favor starting a statin in someone whose other risk factors alone would not clearly warrant it.18PubMed Central. Considerations for routinely testing for high lipoprotein(a) A comprehensive lipid assessment that includes cholesterol, triglycerides, HDL, LDL, non-HDL cholesterol, and a one-time Lp(a) measurement enables clinicians to quantify lipid-related risk and monitor treatment effects.19PubMed Central. Lipid Profile and Lipoprotein(a) Testing
NMR (nuclear magnetic resonance) lipoprotein testing goes a step further by measuring the actual number and size of lipoprotein particles.20PubMed Central. Clinical Relevance of Nuclear Magnetic Resonance LipoProfile A study of healthy middle-aged women found that those who went on to have heart attacks or strokes had higher LDL particle concentrations and smaller LDL particle sizes at baseline than women who did not.21PubMed. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women This kind of testing is not routine and is usually ordered when standard results do not fully explain someone’s risk, but it is available and covered by many insurers.
Medications and Conditions That Can Raise Your Numbers
High cholesterol is not always about diet and genetics. A surprising number of common medications can shift your lipid levels, sometimes dramatically. A review of drug-induced lipid changes found that diuretics, beta-blockers, certain oral contraceptives, immunosuppressive drugs, and HIV protease inhibitors can increase total cholesterol by up to 40%, LDL by up to 50%, and triglycerides by as much as 300%. Some of these drugs also lower HDL by up to 50%.22PubMed. Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels Isotretinoin (used for severe acne), certain antipsychotic medications, and antiseizure drugs can spike triglycerides specifically.
Medical conditions that can raise cholesterol include underactive thyroid (hypothyroidism), kidney disease, liver disease, and poorly controlled diabetes. If your lipid panel comes back surprisingly high, particularly if it was previously normal, your doctor should consider whether a medication change or an undiagnosed condition might be the cause before jumping straight to cholesterol-lowering drugs. Treating the underlying problem can sometimes resolve the lipid issue entirely.
How Ethnicity Affects Cholesterol Patterns and Risk
Cholesterol risk is not one-size-fits-all. Research consistently shows that different racial and ethnic groups have different typical lipid profiles, and the relationship between those profiles and actual heart disease risk varies too. A large analysis found that compared with non-Hispanic white Americans, most minority groups had higher rates of elevated triglycerides and low HDL, with the notable exception of Black Americans, who generally have lower triglycerides and higher HDL.23PubMed Central. Racial/ethnic differences in dyslipidemia patterns
This apparently “healthier” lipid profile in Black Americans is paradoxical, because Black Americans still experience a disproportionate burden of cardiovascular disease and type 2 diabetes. Evidence suggests the relationship between lipid numbers and actual disease risk differs across ethnic groups, which means standard lipid cutoffs may underidentify Black Americans who are at real risk.24PubMed Central. Interethnic Variation in Lipid Profiles: Implications for Underidentification of African-Americans at risk for Metabolic Disorders Similarly, a study from Northern Manhattan found that the protective association of higher HDL was strong in non-Hispanic white participants but essentially absent in Hispanic participants, suggesting the same HDL number carries different meaning depending on who you are.25PubMed Central. Race-ethnic differences in the relationship between lipid profile components and risk of myocardial infarction: the Northern Manhattan Study The point is not to make you second-guess your lab results, but to understand that your doctor should be interpreting them in the context of your full picture, not just comparing a single number against a universal cutoff.
When Diet Makes the Numbers Hard to Interpret
Very-low-carbohydrate and ketogenic diets can produce lipid panels that look alarming on paper. In one documented case, a man’s total cholesterol jumped from 160 to 450 mg/dL and his LDL soared from 95 to 321 mg/dL after seven months on a high-fat ketogenic diet, even as his HDL rose substantially from 48 to 109 mg/dL.26PubMed Central. A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic Diet A study in children on a medically prescribed ketogenic diet (used for seizure control) also found substantial increases in total cholesterol, LDL, VLDL, triglycerides, and apoB at six months, with effects that persisted but moderated over two years.27JAMA. Effect of a High-Fat Ketogenic Diet on Plasma Levels of Lipids, Lipoproteins, and Apolipoproteins in Children
How much cardiovascular risk these changes represent is genuinely debated. The standard lipid panel was developed assuming a typical mixed diet, and some researchers argue that in the context of very low carbohydrate intake, the conventional LDL number overstates risk because the underlying particle characteristics change. Whether that argument holds up long-term remains unresolved. If you follow a high-fat diet and your numbers spike, advanced testing like apoB or NMR particle analysis can help clarify whether you have truly more harmful particles in circulation or simply more cholesterol riding on a normal number of particles.
Familial Hypercholesterolemia and Genetic Testing
If your LDL cholesterol is persistently very high, especially above roughly 190 mg/dL without an obvious secondary cause, or if close relatives had heart attacks before age 55 (men) or 65 (women), familial hypercholesterolemia is a real possibility. FH is one of the most common serious genetic conditions, yet fewer than 10% of cases are diagnosed in most countries. Expert consensus panels now recommend that genetic testing become standard care for patients with definite or probable FH, as well as their at-risk family members. The testing typically covers three genes: LDLR, APOB, and PCSK9.28PubMed. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel
In a Polish study, a disease-causing mutation was found in 41% of people referred for FH genetic testing. Younger adults (under 40) were far more likely to carry a mutation than older adults, which makes sense because people with genetic cholesterol disorders tend to get flagged earlier. The study also found that the LDL threshold for a genetic diagnosis of FH varied by age, being lower in younger people.29PubMed. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland A confirmed genetic diagnosis does more than explain your own numbers; it gives every blood relative a reason to get tested, since each first-degree family member has a 50% chance of inheriting the same mutation.
How Your Numbers Fit Into Actual Risk
Knowing your cholesterol numbers is the first step, but the numbers alone do not tell you what to do about them. The same LDL level can be low-risk in a 30-year-old non-smoker and high-risk in a 55-year-old with diabetes. U.S. prevention guidelines recommend using a risk calculator, specifically the Pooled Cohort Equations, to estimate your 10-year probability of a heart attack or stroke as a starting point for a shared discussion between you and your doctor about treatment.30PubMed. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease These calculators combine your cholesterol values with age, blood pressure, smoking status, and diabetes status to produce a personalized estimate.
When the calculator puts you in a middle zone where the decision to treat is not obvious, coronary artery calcium (CAC) scoring can add useful information. This is a specialized CT scan that measures calcium deposits in your heart’s arteries, a direct indicator of plaque that has already formed. The 2022 American College of Cardiology expert consensus pathway incorporated CAC into LDL cholesterol goal-setting, recommending an LDL target below 70 mg/dL when the CAC score exceeds 100 or is above the 75th percentile for age and sex.31PubMed Central. LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway A CAC score of zero, on the other hand, is reassuring and may allow you and your doctor to defer medication even when cholesterol alone looks borderline.
Emerging Ways to Monitor Cholesterol
The blood draw may not be the only option forever. Researchers are developing non-invasive methods to monitor lipids using optical sensors and tiny lab-on-a-chip devices. One approach uses a 3D-printed microfluidic chip that detects cholesterol in saliva rather than blood. Early testing showed it could reliably detect low concentrations and its results correlated well with standard laboratory methods.32PubMed Central. Lipid monitoring using non-invasive measurement technologies and machine learning: a systematic review Machine-learning algorithms are also being paired with wearable sensors and imaging data to estimate lipid levels without a blood draw. None of these are ready for clinical use yet, but the direction is clear: the future of cholesterol monitoring likely involves less fasting, fewer needles, and more frequent data points than the once-every-five-years lab visit most people manage today.